In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

It’s the latest step from pharmacy benefit managers to respond to relentless criticism from politicians and regulators over ...

A district court in New Jersey ruled that the plaintiff lacked standing for certain claims, but there is a chance the case ...

Good afternoon, and welcome to the Alexandria Real Estate Equities fourth-quarter and year end 2024 conference call. (Operator Instructions) Please note this event is being recorded. I would now like ...

Q4 2024 Earnings Call Transcript January 28, 2025 Operator: Good afternoon, and welcome to the Alexandria Real Estate ...

TD Cowen analyst Ryan Langston maintained a Buy rating on Cigna (CI – Research Report) today and set a price target of $391.00. The company’s ...